Global HMO Milk Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global HMO Milk Powder market size was valued at US$ 4013 million in 2024 and is forecast to a readjusted size of USD 7971 million by 2031 with a CAGR of 10.7% during review period.
HMO Milk Powder refers to infant formula enriched with Human Milk Oligosaccharides (HMOs), which are complex carbohydrates naturally found in human breast milk. HMOs play a crucial role in infant nutrition and overall health by promoting gut microbiome development, strengthening the immune system, and preventing infections. These oligosaccharides are not fully digestible by infants, but they serve as prebiotics that selectively support the growth of beneficial bacteria in the gut, thereby enhancing overall health.
HMO milk powder products are designed to replicate the nutritional composition of breast milk as closely as possible, especially for infants who are unable to be breastfed. They are typically available in various stages to match the different nutritional needs of infants as they grow. These stages include:
Stage 1 (0-6 months): Formulas in this category are designed to be the sole source of nutrition for newborns, aiming to closely mimic the composition of breast milk. They typically contain a balanced mix of proteins, fats, carbohydrates, vitamins, and minerals to support rapid growth and development.
Stage 2 (6-12 months): At this stage, infants begin to consume solid foods, but formula continues to be a significant part of their diet. Stage 2 HMO formulas provide additional nutrients to support cognitive development, immune health, and the overall physical growth of the infant.
Stage 3 (12 months and above): Formulas for older infants are designed to provide higher levels of energy, vitamins, and minerals to meet the nutritional needs of toddlers who are more active and have a higher metabolic rate.
HMO milk powder is regarded as a premium product, with its key selling point being the presence of these oligosaccharides, which are believed to provide benefits similar to those of breast milk. HMOs in milk powder are often derived through advanced biotechnological processes such as fermentation, making them available to a wider population of infants globally. The range of HMOs included in these formulas can vary, with some brands incorporating specific types like 2'-fucosyllactose, which is known for its immunological benefits.
The growth of the HMO milk powder market is driven by the increasing demand for infant formulas that can support healthy immune development, gut health, and overall growth, especially in regions where access to breastfeeding is limited or where working mothers prefer formula feeding. As awareness about the benefits of HMOs increases, more parents are opting for these premium formulas over regular infant formulas.
Market Development Opportunities: The global market for HMO milk powder has seen significant growth in recent years, with increased demand for premium infant formulas containing human milk oligosaccharides. This demand is particularly high in developing regions like China, Southeast Asia, and India, where the middle class is expanding and there is an increasing awareness about the importance of infant nutrition. Parents in these regions are becoming more conscious of the nutritional quality of infant formula, especially in light of the growing concerns about food safety and the health benefits of breast milk substitutes.
The rise of e-commerce and online shopping platforms has also expanded market access, allowing brands to reach more consumers globally. As more parents research the nutritional value of infant formulas, they are more likely to choose products that offer advanced formulations like HMO-based milk powders. The growing preference for convenience, coupled with the desire for better nutrition, presents substantial market opportunities for HMO milk powder manufacturers.
Key Drivers:
Health and Wellness Awareness: As parents increasingly seek to provide the best possible nutrition for their children, awareness of the benefits of HMO in infant nutrition has surged. HMOs are believed to enhance immune function, support brain development, and improve gut health, making them highly desirable.
Technological Advancements in HMO Production: The development of advanced biotechnologies, such as fermentation processes for HMO production, has made it more cost-effective to incorporate these beneficial oligosaccharides into infant formulas. This has driven the proliferation of HMO milk powders in the market.
Increased Working Mothers: With more mothers returning to work after childbirth, formula feeding has become a more practical solution for many families. The demand for high-quality, nutritious formulas has risen as a result.
Risks:
Regulatory Challenges: The infant formula industry is highly regulated, with strict guidelines regarding product claims and nutritional content. HMO milk powders, particularly those making health claims about immune support or brain development, face intense scrutiny from regulatory bodies. Any failure to comply with these regulations could harm a brand’s reputation and market position.
Supply Chain and Production Costs: The production of HMOs still relies on specialized biotechnologies that can be expensive. Any disruptions in the supply chain or fluctuations in raw material costs could affect production and pricing. Moreover, scaling up HMO production to meet demand could involve significant investment and operational challenges.
Consumer Skepticism: While HMOs are marketed as a key component of premium infant formulas, some parents remain skeptical about the long-term benefits of these added ingredients. Additionally, the growing demand for organic and natural products could lead to concerns about the artificial nature of HMO production.
Market Concentration: The market for HMO milk powders is largely concentrated among a few dominant players, such as Nestlé, Danone, Abbott, and Mead Johnson. These multinational corporations have the resources to invest in research and development and have established brand recognition and distribution networks. However, smaller brands that specialize in HMO-enriched formulas are also emerging, targeting niche markets or specific consumer segments looking for specialized nutritional products.
Downstream Demand Trends: The demand for premium, nutritionally advanced milk formulas, including those with HMO, is expected to continue to grow as parents increasingly prioritize infant health and seek products that can enhance immune system development, gut health, and cognitive function. There is also a growing interest in transparency and ethical sourcing, with more consumers preferring organic, non-GMO, and sustainably sourced ingredients in their children’s products. As parents seek more information on the nutritional content and production processes of infant formulas, brands will need to provide greater transparency in their marketing and product labeling.
Latest Technologies: The production of HMOs has benefited from significant advances in biotechnology, particularly through fermentation processes that allow for more efficient and cost-effective production of these oligosaccharides. This has made it feasible to include HMOs in infant formulas without significantly raising costs. Additionally, the use of nanoencapsulation and other advanced delivery technologies is being explored to enhance the bioavailability and absorption of HMOs, ensuring that infants can derive the maximum benefit from these added ingredients. Furthermore, research into the specific effects of various types of HMOs (e.g., 2'-fucosyllactose and lacto-N-neotetraose) continues to reveal new insights into their potential health benefits, driving further innovation in the formulation of infant milk powders.
In conclusion, the HMO milk powder market presents significant opportunities for growth, driven by the increasing demand for advanced infant nutrition. However, manufacturers must navigate regulatory hurdles, supply chain challenges, and consumer skepticism to capitalize on these opportunities. The integration of cutting-edge biotechnologies and a focus on transparency and consumer education will be crucial to success in this rapidly expanding market.
This report is a detailed and comprehensive analysis for global HMO Milk Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Milk Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Milk Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Milk Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Milk Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL
Others
Market segment by Application
Online Channel
Specialty Store
Supermarket
Others
Major players covered
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Milk Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Milk Powder, with price, sales quantity, revenue, and global market share of HMO Milk Powder from 2020 to 2025.
Chapter 3, the HMO Milk Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Milk Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HMO Milk Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Milk Powder.
Chapter 14 and 15, to describe HMO Milk Powder sales channel, distributors, customers, research findings and conclusion.
HMO Milk Powder refers to infant formula enriched with Human Milk Oligosaccharides (HMOs), which are complex carbohydrates naturally found in human breast milk. HMOs play a crucial role in infant nutrition and overall health by promoting gut microbiome development, strengthening the immune system, and preventing infections. These oligosaccharides are not fully digestible by infants, but they serve as prebiotics that selectively support the growth of beneficial bacteria in the gut, thereby enhancing overall health.
HMO milk powder products are designed to replicate the nutritional composition of breast milk as closely as possible, especially for infants who are unable to be breastfed. They are typically available in various stages to match the different nutritional needs of infants as they grow. These stages include:
Stage 1 (0-6 months): Formulas in this category are designed to be the sole source of nutrition for newborns, aiming to closely mimic the composition of breast milk. They typically contain a balanced mix of proteins, fats, carbohydrates, vitamins, and minerals to support rapid growth and development.
Stage 2 (6-12 months): At this stage, infants begin to consume solid foods, but formula continues to be a significant part of their diet. Stage 2 HMO formulas provide additional nutrients to support cognitive development, immune health, and the overall physical growth of the infant.
Stage 3 (12 months and above): Formulas for older infants are designed to provide higher levels of energy, vitamins, and minerals to meet the nutritional needs of toddlers who are more active and have a higher metabolic rate.
HMO milk powder is regarded as a premium product, with its key selling point being the presence of these oligosaccharides, which are believed to provide benefits similar to those of breast milk. HMOs in milk powder are often derived through advanced biotechnological processes such as fermentation, making them available to a wider population of infants globally. The range of HMOs included in these formulas can vary, with some brands incorporating specific types like 2'-fucosyllactose, which is known for its immunological benefits.
The growth of the HMO milk powder market is driven by the increasing demand for infant formulas that can support healthy immune development, gut health, and overall growth, especially in regions where access to breastfeeding is limited or where working mothers prefer formula feeding. As awareness about the benefits of HMOs increases, more parents are opting for these premium formulas over regular infant formulas.
Market Development Opportunities: The global market for HMO milk powder has seen significant growth in recent years, with increased demand for premium infant formulas containing human milk oligosaccharides. This demand is particularly high in developing regions like China, Southeast Asia, and India, where the middle class is expanding and there is an increasing awareness about the importance of infant nutrition. Parents in these regions are becoming more conscious of the nutritional quality of infant formula, especially in light of the growing concerns about food safety and the health benefits of breast milk substitutes.
The rise of e-commerce and online shopping platforms has also expanded market access, allowing brands to reach more consumers globally. As more parents research the nutritional value of infant formulas, they are more likely to choose products that offer advanced formulations like HMO-based milk powders. The growing preference for convenience, coupled with the desire for better nutrition, presents substantial market opportunities for HMO milk powder manufacturers.
Key Drivers:
Health and Wellness Awareness: As parents increasingly seek to provide the best possible nutrition for their children, awareness of the benefits of HMO in infant nutrition has surged. HMOs are believed to enhance immune function, support brain development, and improve gut health, making them highly desirable.
Technological Advancements in HMO Production: The development of advanced biotechnologies, such as fermentation processes for HMO production, has made it more cost-effective to incorporate these beneficial oligosaccharides into infant formulas. This has driven the proliferation of HMO milk powders in the market.
Increased Working Mothers: With more mothers returning to work after childbirth, formula feeding has become a more practical solution for many families. The demand for high-quality, nutritious formulas has risen as a result.
Risks:
Regulatory Challenges: The infant formula industry is highly regulated, with strict guidelines regarding product claims and nutritional content. HMO milk powders, particularly those making health claims about immune support or brain development, face intense scrutiny from regulatory bodies. Any failure to comply with these regulations could harm a brand’s reputation and market position.
Supply Chain and Production Costs: The production of HMOs still relies on specialized biotechnologies that can be expensive. Any disruptions in the supply chain or fluctuations in raw material costs could affect production and pricing. Moreover, scaling up HMO production to meet demand could involve significant investment and operational challenges.
Consumer Skepticism: While HMOs are marketed as a key component of premium infant formulas, some parents remain skeptical about the long-term benefits of these added ingredients. Additionally, the growing demand for organic and natural products could lead to concerns about the artificial nature of HMO production.
Market Concentration: The market for HMO milk powders is largely concentrated among a few dominant players, such as Nestlé, Danone, Abbott, and Mead Johnson. These multinational corporations have the resources to invest in research and development and have established brand recognition and distribution networks. However, smaller brands that specialize in HMO-enriched formulas are also emerging, targeting niche markets or specific consumer segments looking for specialized nutritional products.
Downstream Demand Trends: The demand for premium, nutritionally advanced milk formulas, including those with HMO, is expected to continue to grow as parents increasingly prioritize infant health and seek products that can enhance immune system development, gut health, and cognitive function. There is also a growing interest in transparency and ethical sourcing, with more consumers preferring organic, non-GMO, and sustainably sourced ingredients in their children’s products. As parents seek more information on the nutritional content and production processes of infant formulas, brands will need to provide greater transparency in their marketing and product labeling.
Latest Technologies: The production of HMOs has benefited from significant advances in biotechnology, particularly through fermentation processes that allow for more efficient and cost-effective production of these oligosaccharides. This has made it feasible to include HMOs in infant formulas without significantly raising costs. Additionally, the use of nanoencapsulation and other advanced delivery technologies is being explored to enhance the bioavailability and absorption of HMOs, ensuring that infants can derive the maximum benefit from these added ingredients. Furthermore, research into the specific effects of various types of HMOs (e.g., 2'-fucosyllactose and lacto-N-neotetraose) continues to reveal new insights into their potential health benefits, driving further innovation in the formulation of infant milk powders.
In conclusion, the HMO milk powder market presents significant opportunities for growth, driven by the increasing demand for advanced infant nutrition. However, manufacturers must navigate regulatory hurdles, supply chain challenges, and consumer skepticism to capitalize on these opportunities. The integration of cutting-edge biotechnologies and a focus on transparency and consumer education will be crucial to success in this rapidly expanding market.
This report is a detailed and comprehensive analysis for global HMO Milk Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Milk Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Milk Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Milk Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Milk Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Milk Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL
Others
Market segment by Application
Online Channel
Specialty Store
Supermarket
Others
Major players covered
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Milk Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Milk Powder, with price, sales quantity, revenue, and global market share of HMO Milk Powder from 2020 to 2025.
Chapter 3, the HMO Milk Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Milk Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HMO Milk Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Milk Powder.
Chapter 14 and 15, to describe HMO Milk Powder sales channel, distributors, customers, research findings and conclusion.
Table of Contents
102 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: HMO Milk Powder by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
